Drug Shortage Report for CABAZITAXEL FOR INJECTION

Last updated on 2023-11-21 History
Report ID 203175
Drug Identification Number 02487497
Brand name CABAZITAXEL FOR INJECTION
Common or Proper name CABAZITAXEL
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) CABAZITAXEL
Strength(s) 45MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 4.5ML
ATC code L01CD
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2023-08-29
Estimated end date 2023-11-17
Actual end date 2023-11-20
Shortage status Resolved
Updated date 2023-11-21
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2023-11-21 English Compare
v10 2023-11-20 French Compare
v9 2023-11-20 English Compare
v8 2023-10-30 French Compare
v7 2023-10-30 English Compare
v6 2023-10-16 French Compare
v5 2023-10-16 English Compare
v4 2023-08-30 English Compare
v3 2023-08-29 French Compare
v2 2023-08-29 English Compare
v1 2023-08-29 English Compare

Showing 1 to 11 of 11